Last reviewed · How we verify
NCT05549674: COPAIN
Copenhagen Cohort of Patients With Shoulder Pain
trial testing The COPAIN study is observational. There is no intervention. in Subacromial Impingement Syndrome in 218 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | Hvidovre University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 218 |
| Start date | 1 September 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- The COPAIN study is observational. There is no intervention.
Conditions studied
- Subacromial Impingement Syndrome — all drugs for Subacromial Impingement Syndrome →
- Subacromial Pain Syndrome — all drugs for Subacromial Pain Syndrome →
- Subacromial Impingement — all drugs for Subacromial Impingement →
Sponsor
Hvidovre University Hospital
Who can join
Adults 18 to 100, any sex, with Subacromial Impingement Syndrome or Subacromial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The COPAIN study is comprised of three studies; a cross-sectional study (study 1), a prospective study (study 2) and a randomized controlled trial (study 3). Study 3 is described in detail in a separate protocol (the SELECT trial protocol) and is not described in further detail here.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Challenge of Diagnosing Patients Presenting With Signs and Symptoms of Subacromial Pain Syndrome: A Descriptive Study of 741 Patients Seen in a Secondary Care Setting.
Witten A, Clausen MB, Thorborg K, Hölmich P, et al · · 2025 · cited 1× · PMID 40303319 · DOI 10.1177/23259671251332942
Verify or expand the search:
- PubMed search for NCT05549674
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subacromial Impingement Syndrome
Currently open trials in the same condition.
- NCT07509021 — Neuropathic Pain, Catastrophizing, and Adherence in SAIS · recruiting
- NCT07293702 — IASTM Effects on Pain, Functionality, and Proprioception in Subacromial Impingement · NA · recruiting
- NCT06778551 — Shoulder School: A Multicenter Prospective Randomized Controlled Study · NA · active not recruiting
- NCT06688214 — Effects of KT and Scapular Stabilization Exercises. · NA · recruiting
- NCT06473142 — RELATION BETWEEN BODY POSTURE AND SHOULDER DYSFUNCTION · recruiting
Other Hvidovre University Hospital trials
Trials by the same sponsor.
- NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
- NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
- NCT07054216 — Probiotic for Infants · NA · recruiting
- NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
- NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05549674 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
- Last refreshed: 8 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05549674.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing